Allegrini, C.
734  Ergebnisse:
Personensuche X
?
1

Immunoglobulin replacement therapy for yellow nail syndrome:

Lo Conte, C. ; Allegrini, C. ; Matucci, A....
Scandinavian Journal of Immunology.  87 (2018)  3 - p. , 2018
 
?
3

Restoration of lost aquatic plant communities: New habitats..:

Beltman, B. ; Allegrini, C.
Netherlands Journal of Aquatic Ecology.  30 (1997)  4 - p. 331-337 , 1997
 
?
5

SANI definition of Clinical Remission in Severe Asthma: a D..:

Canonica GW ; Blasi F ; Carpagnano GE...
info:eu-repo/semantics/altIdentifier/pmid/37558162.  , 2023
 
?
6

Mild/Moderate Asthma Network in Italy (MANI): a long-term o..:

Braido F ; Blasi F ; Canonica GW...
info:eu-repo/semantics/altIdentifier/pmid/34469268.  , 2022
 
?
7

Economic impact of mepolizumab in uncontrolled severe eosin..:

Bagnasco D ; Povero M ; Pradelli L...
info:eu-repo/semantics/altIdentifier/pmid/33598095.  , 2021
 
?
8

Economic impact of mepolizumab in uncontrolled severe eosin..:

Bagnasco D ; Povero M ; Pradelli L...
info:eu-repo/semantics/altIdentifier/pmid/33598095.  , 2021
 
?
9

Severe asthma: One disease and multiple definitions:

Bagnasco D ; Paggiaro P ; Latorre M...
info:eu-repo/semantics/altIdentifier/pmid/34871335.  , 2021
 
?
10

Economic impact of mepolizumab in uncontrolled severe eosin..:

Bagnasco D ; Povero M ; Pradelli L...
info:eu-repo/semantics/altIdentifier/wos/WOS:000632884100009.  , 2021
 
?
11

Severe asthma: One disease and multiple definitions:

Bagnasco D ; Paggiaro P ; Latorre M...
info:eu-repo/semantics/altIdentifier/pmid/34871335.  , 2021
 
?
12

Economic impact of mepolizumab in uncontrolled severe eosin..:

Bagnasco D ; Povero M ; Pradelli L...
info:eu-repo/semantics/altIdentifier/pmid/33598095.  , 2021
 
?
13

Economic impact of mepolizumab in uncontrolled severe eosin..:

Bagnasco D ; Povero M ; Pradelli L...
info:eu-repo/semantics/altIdentifier/wos/WOS:000632884100009.  , 2021
 
?
14

Severe asthma: One disease and multiple definitions:

Bagnasco D ; Paggiaro P ; Latorre M...
info:eu-repo/semantics/altIdentifier/wos/WOS:000724917300002.  , 2021
 
?
15

Economic impact of mepolizumab in uncontrolled severe eosin..:

Bagnasco D ; Povero M ; Pradelli L...
info:eu-repo/semantics/altIdentifier/wos/WOS:000632884100009.  , 2021
 
1-15